AG
BIIB icon

Algert Global’s Biogen BIIB Stock Holding History

Algert Global’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,196
Closed -$1M – 333
2016
Q3 		$1M Sell
3,196
-781
-20% -$231K 0.29% 146
2016
Q2 		$962K Buy
+3,977
New +$1.05M 0.39% 76
2015
Q3 		– Sell
-830
Closed -$335K – 310
2015
Q2 		$335K Sell
830
-40
-5% -$16.1K 0.18% 201
2015
Q1 		$367K Sell
870
-380
-30% -$150K 0.2% 193
2014
Q4 		$424K Buy
1,250
+330
+36% +$107K 0.25% 160
2014
Q3 		$304K Buy
+920
New +$303K 0.23% 183

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Algert Global's BIIB Position: Q4 2016 in Review

Algert Global sold out of Biogen (BIIB) in Q4 2016, closing a stake of 3,196 shares — an estimated $1M sold.

Algert Global first reported a position in BIIB in Q3 2014 and held it in 6 quarters. The position peaked at $1M in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Algert Global reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Algert Global sold 3,196 Biogen shares in Q4 2016, an estimated $1M.
  • Algert Global first reported a position in Biogen in Q3 2014 and held it in 6 quarters.
  • Algert Global's Biogen position peaked at $1M in Q3 2016.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Algert Global's 13F filing for Q4 2016, filed 26 Jan 2017.